The Union Health Ministry has proposed a new rule requiring imported drugs to have a residual shelf life of at least 12 months at the time of import. The draft amendment to the Drugs and Cosmetics Rules, 1945, was published on June 26, 2026, and aims to streamline the pharmaceutical supply chain while ensuring patients receive quality medicines.
Key Provisions of the Proposed Amendment
The amendment mandates that all imported drugs must have a minimum residual shelf life of 12 months from the date of import. This applies to both bulk drugs and finished formulations. The proposal is open for public feedback for 45 days before being finalized.
According to the Ministry, the move is intended to prevent the import of drugs that are close to their expiry date, which can lead to wastage and compromise patient safety. It also aims to reduce the burden on regulatory authorities by ensuring that only drugs with adequate shelf life enter the Indian market.
Impact on Pharmaceutical Supply Chain
The proposal is expected to benefit all stakeholders in the pharmaceutical supply chain. Importers will need to ensure that drugs are shipped with sufficient shelf life, potentially reducing the frequency of shipments and lowering logistics costs. Distributors and retailers will have more time to sell the products, reducing the risk of expired stock. Patients will have access to medicines that are effective for longer periods.
However, some industry experts have expressed concerns that the rule could lead to supply shortages for certain drugs, especially those with short shelf lives or those manufactured in distant countries. The Ministry has stated that it will consider these concerns during the consultation period.
Background and Rationale
The current rules do not specify a minimum residual shelf life for imported drugs, leading to cases where drugs with only a few months of shelf life are imported. This has resulted in increased wastage and regulatory challenges. The proposed amendment aligns with global best practices, where many countries require a minimum shelf life of 12 months for imported pharmaceuticals.
According to a Ministry official, the move is part of a broader effort to strengthen the drug regulatory framework in India. The official stated, "This proposal will enhance the efficiency of the pharmaceutical supply chain and ensure that patients receive medicines that are safe and effective throughout their intended use."
Next Steps
The draft amendment has been published for public comment. Stakeholders, including pharmaceutical companies, importers, and patient groups, are invited to submit their feedback within 45 days. After considering the comments, the Ministry will finalize the rule and notify it in the official gazette.
The proposed rule is expected to come into effect within six months of notification, giving the industry time to adjust to the new requirements.
